Antibody Targeting of TGF-β in Cancer Patients
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2176-2189
Author(s):
Scott Lonning, Joan Mannick and John M. McPherson
TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2190-2202
Author(s):
Leona E. Ling and Wen-Cherng Lee
The Multifaceted Activities of Mammalian Defensins
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
4254-4269
Author(s):
Eusondia Arnett and Stephanie Seveau
Adult Neural Stem Cells: Response to Stroke Injury and Potential for Therapeutic Applications
Journal:
Current Stem Cell Research & Therapy
Volume:
6
Page:
327-338
Author(s):
Basam Z. Barkho and Xinyu Zhao
Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
10
Page:
497-508
Author(s):
Michael W. Stewart
The Immunoproteasome: An Emerging Therapeutic Target
Journal:
Current Topics in Medicinal Chemistry
Volume:
11
Page:
2923-2930
Author(s):
Wooin Lee and Kyung Bo Kim
The Offer of Chemistry to Targeted Therapy in Cancer
Journal:
Recent Patents on Biotechnology
Volume:
5
Page:
174-182
Author(s):
Ikram Jemel, Karim Jellali, Jihene Elloumi and Sami Aifa
The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4872-4884
Author(s):
M. Cantile, R. Franco, G. Schiavo, A. Procino, L. Cindolo, G. Botti and C. Cillo
Anticancer Metallotherapeutics in Preclinical Development
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4738-4752
Author(s):
G. N. Kaluderovic and R. Paschke
RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Journal:
Current Molecular Medicine
Volume:
11
Page:
686-695
Author(s):
K. J. Doherty, C. McKay, K. K. Chan and M. K. El-Tanani